Company
Novo Nordisk Limited
Novo Nordisk Limited is an active UK company (number 01118740), incorporated 1973, with 3 current directors including Sebnem Avsar Tuna and Thomas Rask Nielsen. Source: Companies House, updated 4th October 2026.
Official record Companies House · updated 4th October 2026 · Sources
Network
The large node is Novo Nordisk Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 29
- Jonas Emil Kongshoj Larsen 2022-2026 View profile
- Frederik Kier 2020-2022 View profile
- Tomas Haagen 2018-2024 View profile
- Pinder Sahota 2018-2024 View profile
- Matt Joseph Regan 2017-2020 View profile
- Doxie Alphonza Jordan 2014-2018 View profile
- Jerzy Roman Gruhn 2013-2016 View profile
- Peter Paul Armand Meeus 2012-2014 View profile
- Martinus Hermanus Soeters 2008-2013 View profile
- Nicholas Barry 2008-2012 View profile
- Soren Jelert 2005-2008 View profile
- Kare Schultz 2005-2008 View profile
- Henrik Juuel Neilsen 2003-2005 View profile
- Klaus Ehrlich 2002-2005 View profile
- Viggo Ludvig Birch 2001-2012 View profile
- Ingelise Saunders 1997-2001 View profile
- Ole Falvig Ramsby 1997-2018 View profile
- Jakob Sorensen 1996-1997 View profile
- Hywel Evans 1995-1997 View profile
- Pal Helmich 2002 View profile
- Lars Almblom Jorgensen 1993 View profile
- Mads Ravn Sorensen 1996 View profile
- Gordon Charles Aylward 1995 View profile
- Matthew O'Flynn 2012-2024 View profile
- Nicholas James Bailey 2011-2012 View profile
- Wendy Helen Lloyd-Goodwin 2009-2011 View profile
- Sandra Roberts 1999-2009 View profile
- Stephen Lawrence Brown 1992-1999 View profile
- David Edwards 1992 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
2 contractsFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…
Framework -
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…
Framework -
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…
Framework
About
- Incorporated
- 18/06/1973
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Novo Nordisk Holding Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Novo Nordisk Limited
is controlled by Novo Nordisk Holding Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Novo Nordisk Holding Limited.
1 other company in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Thomas Rask Nielsen Director · appointed 2024
- Sebnem Avsar Tuna Director · appointed 2025
- Nicholas James Bailey Director · appointed 2008
Directors past 6 years
- Nicholas James Bailey Director · appointed 2008
First-time vs portfolio directors
First-time (2)
- Sebnem Avsar Tuna Director · appointed 2025
- Nicholas James Bailey Director · appointed 2008
Portfolio (1)
- Thomas Rask Nielsen Director · appointed 2024
Left in the last 12 months
- Jonas Emil Kongshoj Larsen Director · appointed 2022 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 01118740
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 4th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data